BUY Lupin Limited — Prakash Gaba

Lupin share price target & all analyst calls

byPrakash GabaHorizon: NA (inferred BTST)30 Jun 2026, 2:37 pm ISTvia CNBC Awaaz.

Entry₹2,430Stated
Target₹2,450
Total upside +0.82% (call closed)
Stop loss₹2,410-0.82% risk
Exit₹2,4101 Jul 2026, 9:42 am
Stop-loss hit-0.82%

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Oct, 12:41 am IST
2 supporting0 opposing
Supports the BUY call (2)

1 other SEBI-registered advisor has an active BTST BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·29 Jun · yesterday

Lupin Limited received tentative approval from the U.S. FDA for Enzalutamide Tablets on June 26, 2026. This is a step towards potential market approval.

NSE · Press Release·26 Jun · 5d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.